background image

Paid Clinical Trials Chesapeake

Discover 395 paid clinical trials in Chesapeake, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Featured

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 10 - 17

Code: NCT06372964

Phase3, Recruiting
Active & Responsive

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: 79 recruiting locations
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819878

Phase3, Recruiting
Active & Responsive

A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

for
Moderately to Severely Active Ulcerative Colitis
Location: 79 recruiting locations
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06589986

Phase3, Recruiting
Active & Responsive

Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults

for
COVID-19
Location: 9 recruiting locations
Sponsor: Ocugen

Sex: All

Age: 18+

Code: NCT05258669

Phase2, Phase3, Recruiting
Active & Responsive

The Influence of Different Mood States and Emotions on the Physiologic, Metabolic, and Perceptual Responses to Feeding Before Exercise

for
Other Gastrointestinal Disorders, Cramp, Abdominal
Location: 1 recruiting location
Sponsor: Old Dominion University

Sex: All

Age: 18 - 55

Code: NCT05217589

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

for
Breast Neoplasms, Brain Neoplasms, Neoplasms by Site, Neoplasms,
Location: 11 recruiting locations
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05386108

Phase1, Phase2, Recruiting
Active & Responsive

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

for
Breast Neoplasms, Breast Cancer
Location: 8 recruiting locations
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06797635

Phase2, Recruiting
Active & Responsive

Food Orders on Blood Glucose and Fuel Use At Rest

for
Glucose Metabolism Disorders, Hunger, Fat Burn
Location: 1 recruiting location
Sponsor: Old Dominion University

Sex: All

Age: 18 - 70

Code: NCT06763562

Recruiting
Active & Responsive

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

for
AAA, AAA - Abdominal Aortic Aneurysm
Location: 24 recruiting locations
Sponsor: Endologix

Sex: All

Age: 21+

Code: NCT05064540

Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: 25 recruiting locations
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase3, Recruiting